Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-10-03

Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Lacosamide in Neonates With Repeated Electroencephalographic Neonatal Seizures [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the efficacy, safety, and pharmacokinetics of lacosamide in neonates with repeated electroencephalographic neonatal seizures was term…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lacosamide (Lacosamide)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Electroencephalographic Neonatal Seizures, Epilepsy | Phase 2 | Status: TERMINATED | Results posted: 2025-10-03